AgeX Therapeutics Inc (AGE) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
AgeX has officially extended the deadline for completing its planned merger with Serina by 60 days, pushing the finalization date from February 29, 2024, to April 29, 2024. This extension allows both AgeX and Serina additional time to finalize the transaction before either party can opt to terminate the agreement unilaterally.
For further insights into AGE stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
